RecruitingPhase 2NCT06868628

A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)

Studying Multiple system atrophy

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Tiziana Life Sciences LTD
Intervention: Foralumab Nasal(drug)
Enrollment: 5 target
Eligibility: 30-85 years · All sexes
Timeline: 2025 – 2027

Study locations (1)

Brigham and Women's Hospital, Boston, Massachusetts, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06868628 on ClinicalTrials.gov

Other trials for Multiple system atrophy

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT07446894
MSA-01 in Multiple System Atrophy
Tokyo University
RECRUITINGPHASE2NCT07197866
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
Teva Branded Pharmaceutical Products R&D LLC
ENROLLING BY INVITATIONNCT07081841
AB-1005 Long-Term Follow-up Study
AskBio Inc
RECRUITINGPHASE1, PHASE2NCT06831500
Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.
Julien Bally
RECRUITINGEARLY PHASE1NCT06765733
The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy
Beijing Tiantan Hospital
RECRUITINGNCT07353463
Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
Ruijin Hospital
RECRUITINGEARLY PHASE1NCT06891703
[18F]ACI-15916 PET in α-synucleinopathies
AC Immune SA
RECRUITINGPHASE2NCT06848231
A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy
Yoda Therapeutics Inc.

See all trials for Multiple system atrophy →

← Back to all trials